Laboratory Equipment

Fremont – October 19, 2026 -- Ultima Genomics' UG200 Sequencing Platform has been selected to power a single-cell immune profiling study of 80,000 UK Biobank blood samples, run with IMU Biosciences to produce a foundational dataset for AI.

Study starts with 80,000 samples and targets the full 500,000-participant cohort

The project combines IMU's High Definition (HD) Immunology platform, the BD FACSDiscover Cell Analyzer platform, the BD Rhapsody single-cell multiomics platform from Waters Corporation and Ultima's sequencing. The initial cohort is 80,000 blood samples from UK Biobank participants. The partners aim to expand across the full UK Biobank cohort of 500,000 participants.

Needham, Mass. – October 16, 2026 -- Evident has launched the Pramana POD, a benchtop whole slide imaging (WSI) scanner that scans at true 40X resolution at 25 slides per hour under defined conditions and targets small and medium-sized pathology laboratories.

Evident extends autonomous Pramana WSI technology to smaller laboratories

The system is built for small and medium-sized labs and for specialty applications within larger institutions. Evident is extending its existing Pramana autonomous WSI technology to this segment as laboratories expand digital workflows amid rising case volumes and operational demands.

Automated imaging aims to cut operator intervention and post-scan QA

The scanner automates imaging with a tissue finder, extensive label detection, and automated focal plane and scan-profile selection. Built-in image-quality assessment is designed to deliver pathologist-ready images and flag scans that may need further review.

Pleasanton – October 16, 2026 -- n6 Tec, Inc. has received ISO 13485:2016 certification from Intertek for its quality management system, covering the manufacture and service of genetic research instrumentation at its Pleasanton, California headquarters.

Certificate 0259003 runs through October 2029

Intertek issued the initial certificate on October 12, 2026. It is valid through October 11, 2029, subject to ongoing surveillance by the certification body.

ISO 13485:2016 is the international quality management standard for organizations that design, manufacture and service medical devices. An independent auditor must verify that documented processes for design controls, supplier management, manufacturing, traceability, corrective and preventive action, and customer feedback exist and are followed.

Chennai – October 16, 2026 -- Zifo has been named a Gamechanger in Healthcare & Pharma in the enterprise segment at the Nasscom AI Gamechangers Awards 2026, for an AI service accelerator that speeds up master data creation for laboratory information management systems (LIMS).

Zifo's accelerator targets manual master data preparation in LIMS projects

Master data is foundational to configuring and implementing a LIMS. The source information is often scattered across PDFs, specifications, procedures and spreadsheets. Finding it, checking it and converting it into structured master data objects takes significant manual effort. The work must also meet the consistency, traceability and auditability that regulated environments expect.

Boston – – October 08, 2026 -- Araceli Biosciences and Ginkgo Bioworks (NYSE: DNA) have integrated Araceli's Endeavor high-content imaging instrument into Nebula, Ginkgo's autonomous laboratory in Boston, adding what the companies describe as the world's fastest high-content imaging system to a facility already running more than 100 automated carts around the clock.

Endeavor images a 1536-well plate in under four minutes

The Endeavor instrument captures and analyzes cellular data from a full 1536-well plate in less than four minutes, running continuously alongside Nebula's other always-on experiments. The system is built on Ginkgo's Reconfigurable Automation Carts (RACs), modular units combining robotic arms, automated sample transport and unified control software that let instruments be added or rearranged as research workflows shift.

Sitges – October 08, 2026 -- MGI Tech Co., Ltd. unveiled its Stereo-seq OMNI Large Chip Design for formalin-fixed, paraffin-embedded (FFPE) tissue samples at the third Conference of the European Society for Spatial Biology (ESSB), held September 28 to October 1 at Hotel Meliá Sitges near Barcelona.

New chip format expands capture area to 2 cm by 3 cm for FFPE research

The design builds on MGI's existing Stereo-seq OMNI V1.1 platform and is built for chip formats up to 2 cm by 3 cm, enabling researchers to profile larger tissues, multiple sections, or tissue microarray layouts within a single spatial experiment. Standard capture areas have limited researchers' ability to view larger or structurally diverse FFPE sections, a constraint the new format is engineered to address.

Gwacheon, South Korea – – October 08, 2026 -- Park Systems Corp. captured 23.8% of global atomic force microscopy (AFM) revenue in 2025, retaining the top industry ranking for a fourth consecutive year from 2022 through 2025, according to QY Research's Global Atomic Force Microscopy Market Report.

Park Systems leads both revenue and unit shipments in 2025

The South Korea-based company sold 340 AFM systems during the year, the highest unit volume among manufacturers tracked in the study, while also topping the market on revenue share.

JOHANNESBURG – October 07, 2026 -- Roche Diagnostics has delivered two molecular testing instruments to the Institut National de Santé Publique (INSP) to expand Ebola testing capacity in the Democratic Republic of Congo, as confirmed cases from the Bundibugyo virus outbreak reached 8,067 with 3,901 deaths as of September 28, 2026.

Case fatality rate hits 48.4% across 60 health zones

UN Health Authority data cited by Roche puts the outbreak's case fatality rate at 48.4% across six provinces, with the World Health Organization classifying the risk level in the DRC as very high and maintaining the event as a public health emergency of international concern.

London – October 06, 2026 -- The global cell culture monitoring biosensors market is set to more than double from USD 413.8 million in 2024 to USD 906.56 million by 2032, expanding at a 10.3% compound annual growth rate, according to a new report from Credence Research Inc. Demand is being driven by biologics manufacturers, cell therapy developers and high-throughput research labs shifting away from manual sampling toward continuous, non-invasive monitoring.

Optical biosensors dominate with 39% technology share in 2024

Optical platforms led the market on strength of real-time, label-free cell analysis capabilities. Electrochemical, mechanical and microfluidic biosensors are gaining ground as labs integrate sensing hardware with automated culture platforms to cut manual intervention and flag process deviations earlier.

Sheridan, Wyo. – October 05, 2026 -- The global in vitro diagnostics (IVD) quality control market is set to climb from $1.7 billion in 2026 to $2.2 billion by 2031, a 5.3% compound annual growth rate, according to a new study by Wissen Research.

Rising testing volumes and regulatory pressure push labs toward automated QC

Growth is driven by expanding testing complexity across clinical chemistry, immunoassay, hematology, and molecular diagnostics, combined with tightening regulatory requirements such as CLIA in the United States. Laboratories are increasingly adopting internal quality controls, third-party control materials, and external quality assessment programs as standard practice.